Study finds how bacterial vaccine demonstrates potential as treatment for cancer immunotherapy – Times of India
Columbia researchers have developed a new microbial cancer vaccine using probiotic bacteria that trains the immune system to target and eliminate cancer cells. This personalized vaccine has shown promising results in mice models, shrinking or eliminating tumors while sparing healthy tissue. The vaccine is more effective than previous peptide-based cancer vaccines and can be tailored…